EEPD1

gene
On this page

Also known as KIAA1706

Summary

EEPD1 (endonuclease/exonuclease/phosphatase family domain containing 1, HGNC:22223) is a protein-coding gene on chromosome 7p14.2, encoding Endonuclease/exonuclease/phosphatase family domain-containing protein 1 (Q7L9B9).

Predicted to enable DNA binding activity and catalytic activity. Involved in positive regulation of cholesterol efflux. Located in plasma membrane.

Source: NCBI Gene 80820 — RefSeq curated summary.

At a glance

  • GWAS associations: 16
  • Clinical variants (ClinVar): 106 total
  • MANE Select transcript: NM_030636

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:22223
Approved symbolEEPD1
Nameendonuclease/exonuclease/phosphatase family domain containing 1
Location7p14.2
Locus typegene with protein product
StatusApproved
AliasesKIAA1706
Ensembl geneENSG00000122547
Ensembl biotypeprotein_coding
OMIM617192
Entrez80820

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 8 protein_coding, 2 retained_intron

ENST00000242108, ENST00000444777, ENST00000468591, ENST00000487069, ENST00000874230, ENST00000874231, ENST00000874232, ENST00000936250, ENST00000960495, ENST00000960496

RefSeq mRNA: 1 — MANE Select: NM_030636 NM_030636

CCDS: CCDS34619

Canonical transcript exons

ENST00000242108 — 8 exons

ExonStartEnd
ENSE000009765543623898536239036
ENSE000011527943628111536281225
ENSE000011528113615325436153674
ENSE000011557253629900736301538
ENSE000011557313615413336155202
ENSE000035187393629699336297187
ENSE000035890963628763936287777
ENSE000036886023628468636284820

Expression profiles

Bgee: expression breadth ubiquitous, 219 present calls, max score 96.35.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.7982 / max 178.4895, expressed in 1371 samples.

FANTOM5 promoters (9 alternative TSS)

Promoter IDTPM avgSamples expressed
781194.80931140
781251.0721393
781180.7578419
781240.6166270
781320.212578
781260.181582
781310.063430
781330.046415
781340.03865

Top tissues by expression

243 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
ventricular zoneUBERON:000305396.35gold quality
hindlimb stylopod muscleUBERON:000425293.98gold quality
gastrocnemiusUBERON:000138893.89gold quality
muscle of legUBERON:000138393.04gold quality
gall bladderUBERON:000211090.98gold quality
ganglionic eminenceUBERON:000402390.96gold quality
C1 segment of cervical spinal cordUBERON:000646990.59gold quality
body of stomachUBERON:000116189.75gold quality
omental fat padUBERON:001041489.58gold quality
peritoneumUBERON:000235889.48gold quality
subcutaneous adipose tissueUBERON:000219089.26gold quality
right lobe of liverUBERON:000111489.23gold quality
lower esophagus muscularis layerUBERON:003583389.22gold quality
lower esophagusUBERON:001347389.20gold quality
adipose tissue of abdominal regionUBERON:000780888.93gold quality
pancreatic ductal cellCL:000207988.53silver quality
apex of heartUBERON:000209888.41gold quality
skin of abdomenUBERON:000141687.99gold quality
body of pancreasUBERON:000115087.89gold quality
esophagogastric junction muscularis propriaUBERON:003584187.72gold quality
endocervixUBERON:000045887.37gold quality
muscle layer of sigmoid colonUBERON:003580587.30gold quality
skin of legUBERON:000151187.25gold quality
descending thoracic aortaUBERON:000234587.17gold quality
spinal cordUBERON:000224087.04gold quality
lower esophagus mucosaUBERON:003583486.97gold quality
stomachUBERON:000094586.57gold quality
popliteal arteryUBERON:000225086.46gold quality
tibial arteryUBERON:000761086.44gold quality
tibialis anteriorUBERON:000138586.10silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.63

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

81 targeting EEPD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4747-5P100.0067.902681
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-4673100.0066.641490
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-12118100.0065.881270
HSA-MIR-4481100.0066.421669
HSA-MIR-453199.9969.703181
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-998599.9872.112939
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-448799.9664.581252
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-146A-5P99.9668.93988
HSA-MIR-146B-5P99.9669.13977
HSA-MIR-7153-5P99.9468.891006
HSA-MIR-368699.9070.532432
HSA-MIR-3529-3P99.9073.553045
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-477999.8666.501583
HSA-MIR-548AR-3P99.8571.263889

Literature-anchored findings (GeneRIF, showing 5)

  • These data demonstrate that genome stability during replication stress is maintained by EEPD1, which initiates HR and inhibits cNHEJ and MMEJ. (PMID:26684013)
  • EEPD1 performs a gatekeeper function for replication fork repair by mediating the fork cleavage that permits initiation of HR-mediated repair and restart of stressed forks (PMID:28049724)
  • EEPD1 is a novel LXR-regulated gene in macrophages and that it promotes cellular cholesterol efflux by controlling cellular levels and activity of ABCA1. (PMID:28082258)
  • The mechanism by which RAD52 depletion causes synthetic lethality in BRCA1 mutant cancer cells depends on the 5’ endonuclease EEPD1, which normally functions to cleave stressed replication forks to initiate HR repair. (PMID:29145865)
  • Super-enhancer-associated EEPD1 facilitates EMT-mediated metastasis by regulating the PI3K/AKT/mTOR pathway in gastric cancer. (PMID:37976838)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_rerioeepd1ENSDARG00000071116
mus_musculusEepd1ENSMUSG00000036611
rattus_norvegicusEepd1ENSRNOG00000006931

Protein

Protein identifiers

Endonuclease/exonuclease/phosphatase family domain-containing protein 1Q7L9B9 (reviewed: Q7L9B9)

All UniProt accessions (2): H7C4A5, Q7L9B9

UniProt curated annotations — full annotation on UniProt →

RefSeq proteins (1): NP_085139* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003583Hlx-hairpin-Hlx_DNA-bd_motifDomain
IPR004509Competence_ComEA_HhHDomain
IPR005135Endo/exonuclease/phosphataseDomain
IPR010994RuvA_2-likeHomologous_superfamily
IPR036691Endo/exonu/phosph_ase_sfHomologous_superfamily
IPR051675Endo/Exo/Phosphatase_dom_1Family

Pfam: PF03372, PF12836

UniProt features (22 total): modified residue 9, sequence variant 3, region of interest 3, compositionally biased region 3, initiator methionine 1, chain 1, lipid moiety-binding region 1, domain 1

Structure

Experimental structures (PDB)

3 structures.

PDBMethodResolution (Å)
9YSFX-RAY DIFFRACTION1.59
9YXYX-RAY DIFFRACTION2
9YI2ELECTRON MICROSCOPY3.6

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q7L9B9-F174.720.40

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (10): 21, 25, 106, 110, 160, 173, 265, 428, 2, 16

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-9029569NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux

MSigDB gene sets: 146 (showing top): GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN, GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX, GOBP_REGULATION_OF_CHOLESTEROL_EFFLUX, GOBP_POSITIVE_REGULATION_OF_STEROL_TRANSPORT, GOBP_POSITIVE_REGULATION_OF_LIPID_TRANSPORT, GOBP_ORGANIC_HYDROXY_COMPOUND_TRANSPORT, GOBP_CHOLESTEROL_EFFLUX, RGTTAMWNATT_HNF1_01, GOBP_DNA_DAMAGE_RESPONSE, GOBP_REGULATION_OF_STEROL_TRANSPORT, HNF1_C, GOBP_STEROL_TRANSPORT, HNF1_01, GOBP_POSITIVE_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_TRANSPORT

GO Biological Process (2): DNA repair (GO:0006281), positive regulation of cholesterol efflux (GO:0010875)

GO Molecular Function (3): DNA binding (GO:0003677), catalytic activity (GO:0003824), protein binding (GO:0005515)

GO Cellular Component (1): plasma membrane (GO:0005886)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
NR1H2 and NR1H3-mediated signaling1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
DNA metabolic process1
DNA damage response1
regulation of cholesterol efflux1
positive regulation of cholesterol transport1
cholesterol efflux1
nucleic acid binding1
molecular_function1
binding1
membrane1
cell periphery1

Protein interactions and networks

STRING

1404 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
EEPD1EXO1Q9UQ84676
EEPD1EME2A4GXA9534
EEPD1DNA2P51530469
EEPD1EXO5Q9H790456
EEPD1SHISA3A0PJX4453
EEPD1SETMARQ53H47433
EEPD1MUS81Q96NY9433
EEPD1TXNDC8Q6A555423
EEPD1RAD52P43351419
EEPD1COX7A2LO14548370
EEPD1ADGRL1O94910353
EEPD1ADGRL2O95490353
EEPD1ADGRL3Q9HAR2353
EEPD1FHIP2AQ5W0V3350
EEPD1MTMR8Q96EF0347

IntAct

36 interactions, top by confidence:

ABTypeScore
MED21MED19psi-mi:“MI:0914”(association)0.880
EEPD1GRIP1psi-mi:“MI:0915”(physical association)0.560
FYTTD1UBA6psi-mi:“MI:0914”(association)0.530
GJB7PALM3psi-mi:“MI:0914”(association)0.530
FSD1UBFD1psi-mi:“MI:0914”(association)0.530
RSBN1SETD1Apsi-mi:“MI:0914”(association)0.530
TMEM185ATSPAN6psi-mi:“MI:0914”(association)0.530
EEPD1psi-mi:“MI:0407”(direct interaction)0.440
MED21MED19psi-mi:“MI:0914”(association)0.350
TIGD5P4HA2psi-mi:“MI:0914”(association)0.350
SDC1ARVCFpsi-mi:“MI:0914”(association)0.350
PCDHGC3HRASpsi-mi:“MI:0914”(association)0.350
NCSTNYES1psi-mi:“MI:0914”(association)0.350
ISG20SRCpsi-mi:“MI:0914”(association)0.350
ZBTB18DNASE1L1psi-mi:“MI:0914”(association)0.350
CERS2VPS37Cpsi-mi:“MI:0914”(association)0.350
MALLGPR89Apsi-mi:“MI:0914”(association)0.350
ANKRD50PPP1R12Apsi-mi:“MI:0914”(association)0.350
GAGE5PPP1R12Apsi-mi:“MI:0914”(association)0.350
DPM2WDR46psi-mi:“MI:0914”(association)0.350
STARD6GSTA4psi-mi:“MI:0914”(association)0.350
FEM1ARNF113Apsi-mi:“MI:0914”(association)0.350
PIGTAKAP8psi-mi:“MI:0914”(association)0.350
PCDHGC3FYNpsi-mi:“MI:0914”(association)0.350
NCSTNALOX5psi-mi:“MI:0914”(association)0.350

BioGRID (48): EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-RNA)

ESM2 similar proteins: A0A2R8Y7D0, A3KMV1, A6NDN8, B9EHT4, D3YWQ0, F1MAB7, O23702, O54788, O75426, O76075, P04413, P0C5J9, P49897, P55073, Q1LZC5, Q28969, Q2T9Z2, Q2VPJ9, Q39491, Q3MHJ7, Q3TGW2, Q4R327, Q57VU6, Q58CZ0, Q5BIR3, Q5I3B1, Q5R4R7, Q5R686, Q5SPX3, Q5XI74, Q6DN07, Q6NXT1, Q6P7W2, Q6QN11, Q6X4W1, Q7L9B9, Q7TPD7, Q80TL4, Q8K485, Q8TBC3

Diamond homologs: A6QPL4, P0AAR8, P0AAR9, P39694, Q14807, Q3MHJ7, Q3TGW2, Q3V300, Q57134, Q5I0E8, Q5REP4, Q5XI74, Q6P3R1, Q6TEQ0, Q7L9B9, A8WFU8, P46837, P57072, P71353, Q45388, Q497V5, Q51062, Q51152, Q5RDI0, Q6IND4, Q8N5C6, Q9I869

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

106 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance93
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2715 predictions. Top by Δscore:

VariantEffectΔscore
7:36164806:G:GGdonor_gain1.0000
7:36238983:A:AGacceptor_gain1.0000
7:36238983:AG:Aacceptor_loss1.0000
7:36238984:G:GCacceptor_loss1.0000
7:36238984:G:GGacceptor_gain1.0000
7:36238984:GC:Gacceptor_gain1.0000
7:36243866:G:GTdonor_gain1.0000
7:36281113:A:AGacceptor_gain1.0000
7:36281114:G:GGacceptor_gain1.0000
7:36281221:AGAAG:Adonor_loss1.0000
7:36281222:GAAGG:Gdonor_loss1.0000
7:36281223:AAGGT:Adonor_loss1.0000
7:36281224:AGGTA:Adonor_loss1.0000
7:36281225:GGTA:Gdonor_loss1.0000
7:36281226:GT:Gdonor_loss1.0000
7:36281227:T:Gdonor_loss1.0000
7:36284781:G:Tdonor_gain1.0000
7:36284815:TTC:Tdonor_gain1.0000
7:36284872:A:Tdonor_gain1.0000
7:36296985:A:AGacceptor_gain1.0000
7:36296986:C:Gacceptor_gain1.0000
7:36296988:TCCAG:Tacceptor_loss1.0000
7:36296991:A:AGacceptor_gain1.0000
7:36296991:AGG:Aacceptor_loss1.0000
7:36296992:G:Aacceptor_loss1.0000
7:36296992:G:GAacceptor_gain1.0000
7:36296992:GGA:Gacceptor_gain1.0000
7:36297160:A:AGdonor_gain1.0000
7:36297161:G:GGdonor_gain1.0000
7:36297189:T:Adonor_loss1.0000

AlphaMissense

3739 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:36154449:T:AI42N1.000
7:36154453:C:AN43K1.000
7:36154453:C:GN43K1.000
7:36154458:C:AA45D1.000
7:36154473:T:AL50Q1.000
7:36154473:T:CL50P1.000
7:36154482:T:CL53P1.000
7:36154506:C:AA61E1.000
7:36154515:T:AI64N1.000
7:36154527:G:CR68P1.000
7:36154544:T:CF74L1.000
7:36154545:T:CF74S1.000
7:36154546:C:AF74L1.000
7:36154546:C:GF74L1.000
7:36154563:T:CL80P1.000
7:36154572:T:AV83D1.000
7:36154596:T:CL91P1.000
7:36154449:T:GI42S0.999
7:36154452:A:TN43I0.999
7:36154457:G:CA45P0.999
7:36154473:T:GL50R0.999
7:36154505:G:CA61P0.999
7:36154515:T:GI64S0.999
7:36154523:T:GY67D0.999
7:36154526:C:GR68G0.999
7:36154544:T:GF74V0.999
7:36154545:T:GF74C0.999
7:36154559:G:CD79H0.999
7:36154560:A:CD79A0.999
7:36154560:A:GD79G0.999

dbSNP variants (sampled 300 via entrez): RS1000011213 (7:36228028 T>C), RS1000013117 (7:36191917 C>A,T), RS1000047791 (7:36269693 T>C), RS1000115245 (7:36185769 C>T), RS1000141587 (7:36228060 C>T), RS1000177805 (7:36217476 C>T), RS1000178127 (7:36262705 C>G,T), RS1000195956 (7:36239825 A>C,T), RS1000201432 (7:36256832 A>C), RS1000211484 (7:36203825 C>T), RS1000222926 (7:36178742 C>T), RS1000266499 (7:36206027 G>T), RS1000309449 (7:36297338 T>C), RS1000313639 (7:36161053 G>A), RS1000322853 (7:36301983 T>C)

Disease associations

OMIM: gene MIM:617192 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

16 associations (top):

StudyTraitp-value
GCST001061_6Platelet count5.000000e-06
GCST001762_559Obesity-related traits3.000000e-06
GCST003194_24Fibrinogen levels3.000000e-09
GCST004121_32Fibrinogen levels4.000000e-08
GCST004122_6Fibrinogen levels9.000000e-09
GCST006626_16Pulse pressure1.000000e-09
GCST007205_6Schizophrenia1.000000e-06
GCST007614_47C-reactive protein levels1.000000e-08
GCST010002_347Refractive error3.000000e-08
GCST010241_425Apolipoprotein A1 levels2.000000e-12
GCST010242_18HDL cholesterol levels1.000000e-16
GCST010242_242HDL cholesterol levels1.000000e-08
GCST010245_60LDL cholesterol levels2.000000e-11
GCST90002385_186High light scatter reticulocyte count6.000000e-10
GCST90002397_500Mean spheric corpuscular volume2.000000e-12
GCST90002405_227Reticulocyte count7.000000e-10

EFO canonical traits (8, from GWAS)

EFO IDTrait name
EFO:0004309platelet count
EFO:0004736aspartate aminotransferase measurement
EFO:0005763pulse pressure measurement
EFO:0004458C-reactive protein measurement
EFO:0004614apolipoprotein A 1 measurement
EFO:0004612high density lipoprotein cholesterol measurement
EFO:0004611low density lipoprotein cholesterol measurement
EFO:0007986reticulocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

44 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aincreases expression, increases methylation3
Leadaffects expression, affects methylation2
Tobacco Smoke Pollutiondecreases expression2
Aflatoxin B1decreases methylation, increases methylation2
aristolochic acid Iincreases expression1
FR900359affects phosphorylation1
dicrotophosincreases expression1
triphenyl phosphateaffects expression1
trichostatin Aaffects expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
sodium arseniteincreases expression1
S-(1,2-dichlorovinyl)cysteinedecreases expression, decreases reaction1
di-n-butylphosphoric acidaffects expression1
abrineincreases expression1
NSC 689534affects binding, decreases expression1
Leflunomideincreases expression1
Acetaminophenincreases expression1
Air Pollutantsincreases abundance, affects expression1
Amiodaroneincreases expression1
Arbutinincreases expression1
Arsenicaffects methylation1
Atrazinedecreases expression1
Benzo(a)pyreneincreases methylation1
Caffeinedecreases phosphorylation1
Calcitrioldecreases expression1
Cisplatinincreases expression1
Copperaffects binding, decreases expression1
Dexamethasoneincreases expression1
Estradiolaffects expression1
Lipopolysaccharidesdecreases expression, decreases reaction1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.